Inactive Instrument

Insiders KaloBios Pharmaceuticals Inc Nasdaq

Equities

US48344T2096

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Apr. 12	Combined Liquidation Plan and Disclosure Statement Filed by Humanigen, Inc.	CI
Mar. 08	Final DIP Financing Approved for Humanigen, Inc.	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Xspray Pharma Names Chief Commercial Officer	23-09-15	MT
Humanigen, Inc. Announces Resignation of Edward Jordan as Chief Commercial Officer	23-09-14	CI
Humanigen, Inc. Announces Board Changes	23-07-25	CI
Opthea Appoints CFO	22-10-24	MT
Opthea Appoints Timothy Morris as CFO	22-10-24	MT
Humanigen, Inc. Announces Executive Changes	22-09-29	CI
Humanigen Chief Medical Officer Adrian Kilcoyne Resigns	22-09-02	MT
Humanigen, Inc. Announces Resignation Adrian Kilcoyne as Chief Medical Officer, Effective September 28, 2022	22-09-02	CI
Insider Buy: Humanigen	22-05-23	MT
Insider Buy: Humanigen	22-03-16	MT
Humanigen, Inc. Elects John Hohneker, MD, and Kevin Xie, PhD, to Board of Directors	21-10-20	CI
Humanigen : Says EMA Appointed Rapporteurs for Pre-Submission Process for COVID-19 Drug Lenzilumab	21-09-28	MT
Humanigen : Announces the European Medicines Agency Has Appointed a Rapporteur and Co-rapporteur as Part of the Process Related to the Planned Submission of a Marketing Authorization Application (MAA) for Lenzilumab	21-09-28	BU
Insider Trends: Humanigen Insider Extends 90-Day Selling Trend	21-08-13	MT
Insider Trends: Insider Prolongs 90-Day Selling Trend at Humanigen	21-07-30	MT
Insider Trends: Insider 90-Day Selling Trend Extended at Humanigen	21-07-23	MT
Insider Trends: Insider 90-Day Selling Trend Extended at Humanigen	21-07-16	MT
Insider Trends: Insider 90-Day Selling Trend Extended at Humanigen	21-07-09	MT
Insider Trends: Insider Prolongs 90-Day Selling Trend at Humanigen	21-07-02	MT
Insider Trends: 90-Day Insider Selling Trend Prolonged at Humanigen	21-06-25	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders KaloBios Pharmaceuticals Inc Nasdaq

Equities

US48344T2096

Insiders

Filters